News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5 Results
Type
Article (1)
Press Release (4)
Section
Business (3)
News (3)
Tag
Alliances (3)
Medical device (1)
Medtech (1)
Date
2018 (2)
2012 (1)
2011 (1)
2010 (1)
5 Results for "enlyton".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Enlyton Release: International Investments Launch Development of Ohio-Based Novel Cancer Agent
Enlyton, Ltd. has signed an agreement for a series of investments by East Sunshine Foresight Fund, the venture capital arm of HEC Pharm of Shenzen, China.
January 4, 2018
·
3 min read
Shenzhen’s HEC Pharm Invests in U.S. Novel Imaging Contrast Company
East Sunshine Foresight Fund will make a “series of investments” of unspecified size in Enlyton, a Columbus, Ohio company developing novel imaging contrast agents.
January 9, 2018
·
1 min read
Business
Enlyton, Ltd. Awarded National Cancer Institute SBIR Phase I Contract for Tumor Targeting Agent for SPECT Imaging of Cancer
September 18, 2012
·
1 min read
Business
ViroMed and Enlyten Medical Technologies Sign Licensing Agreement to Develop Humanized Antibody to TAG-72 for Cancer Detection
February 25, 2011
·
2 min read
BioMidwest
New Data from Enlyten Medical Technologies Supports Use of an Antigen-Directed, Cancer-Specific Targeting Agent for PET-Based Imaging
September 13, 2010
·
1 min read
